Amelia P.

Amelia P. has a diverse work experience in the field of medical research and engineering. Amelia began their professional career as an Engineering Intern at Biometic Pty Ltd in 2010. Amelia then worked as a Research Scientist at the Australian Nuclear Science and Technology Organisation from 2011 to 2012. During this time, they independently conducted research on the structure of biological membranes and their interaction with antimicrobial and anti-cancer peptides.

In 2012, Amelia joined the Children's Cancer Institute as a PhD Candidate. Amelia 'sresearch focused on the role of betaIII-tubulin in Non-Small Cell Lung Cancer. Amelia utilized cutting-edge gene-editing techniques and molecular biology approaches to study the function of this protein in cancer cell cultures. Amelia 'sfindings provided valuable insights into the clinical implications of betaIII-tubulin expression.

Following their PhD, Amelia worked as a Research Officer at the Children's Cancer Institute from 2016 to 2017. Amelia used live cell confocal microscopy and mass spectrometry to investigate the function of betaIII-tubulin within the intracellular microtubule network and its broader role in Non-Small Cell Lung Cancer cells.

In 2017, Amelia joined the National Cancer Institute as a Postdoctoral Research Fellow and continued their research on betaIII-tubulin. Amelia held this position until 2019, when they joined the Garvan Institute of Medical Research as a Postdoctoral Researcher. Further details about their role at the Garvan Institute are not provided in the given information.

Overall, Amelia P. has demonstrated expertise in medical research, with a particular focus on the study of betaIII-tubulin in cancer. Amelia has experience in utilizing advanced scientific techniques and technologies to gain insights into the mechanisms and clinical implications of this protein.

Amelia P. completed their Bachelor's Degree in Biomedical Engineering and Advanced Biochemistry from the Faculty of Engineering at the University of Sydney, attending from 2006 to 2010. Amelia later pursued a Doctor of Philosophy (Ph.D.) at the Faculty of Medicine, University of New South Wales and Children's Cancer Institute, specializing in Tumourigenesis and Chemotherapy Resistance in Lung Cancer, from 2012 to 2016.